PTGS2 and cancer: Studies have shown that PI3K upregulation also enhances prostaglandin-endoperoxide synthase-2 (PTGS2, also known as cyclooxygenase-2) activity and prostaglandin E2 synthesis [32], which promotes cancer cell proliferation and inhibits apoptosis [33, 34].